Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors

Cell Adhesion and Migration

Volumn 5, Issue 5, 2011, Pages 395-401

  Mostovich, Luydmila A ^a   Prudnikova, Tatiana Y ^a   Kondratov, Aleksandr G ^b   Loginova, Dina ^c   Vavilov, Pavel V ^a   Rykova, Valentina I ^b   Sidorov, Sergei V ^d   Pavlova, Tatiana V ^e   Kashuba, Vladimir I ^b,e   Zabarovsky, Eugene R ^e,f   Grigorieva, Elvira V ^a,e  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^b INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^c INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^d Municipal Central Hospital NI   (Russian Federation)

^e STOCKHOLM SÖDER HOSPITAL   (Sweden)

^f LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Bisulfite sequencing; Breast cancer; Expression; Integrin alpha9; ITGA9; Methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA INTEGRIN; ALPHA9 INTEGRIN; MESSENGER RNA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; EPIGENETICS; GENE ACTIVATION; GENE INACTIVATION; GENE SILENCING; HUMAN; HUMAN TISSUE; INTRON; METHYLATION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 80053456567     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.5.5.17949     Document Type: Article

References (40)

1. Arnaout MA, Goodman SL, Xiong JP. Structure and mechanics of integrin-based cell adhesion. Curr Opin Cell Biol 2007; 19:495-507; PMID:17928215; http:// dx.doi.org/10.1016/j.ceb.2007.08.002.
2. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007; 25:619-47; PMID:17201681; http://dx.doi. org/10.1146/annurev.immunol.25.022106.141618.
3. Soung YH, Clifford JL, Chung J. Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression. BMB Rep 2010; 43:311- 8; PMID:20510013; http://dx.doi.org/10.5483/ BMBRep.2010.43.5.311.
4. Stupack DG, Cheresh DA. Integrins and angiogenesis. Curr Top Dev Biol 2004; 64:207-38; PMID:15563949; http://dx.doi.org/10.1016/S0070-2153(04)64009-9.
5. Rathinam R, Alahari SK. Important role of integrins in the cancer biology. Cancer Metastasis Rev 2010; 29:223-37; PMID:20112053; http://dx.doi. org/10.1007/s10555-010-9211-x.
6. Wang Z, Chui WK, Ho PC. Integrin targeted drug and gene delivery. Expert Opin Drug Deliv 2010; 7:159-71; PMID:20095940; http://dx.doi. org/10.1517/17425240903468696.
7. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10:9-22; PMID:20029421; http:// dx.doi.org/10.1038/nrc2748.
8. Rüegg C, Alghisi GC. Vascular integrins: therapeutic and imaging targets of tumor angiogenesis. Recent Results Cancer Res 2010; 180:83-101; PMID:20033379; http://dx.doi.org/10.1007/978-3- 540-78281-0-6.
9. Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010; 339:269-80; PMID:19693543; http://dx.doi.org/10.1007/s00441-009-0834-6.
10. Palmer EL, Ruegg C, Ferrando R, Pytela R, Sheppard D. Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol 1993; 123:1289-97; PMID:8245132; http://dx.doi. org/10.1083/jcb.123.5.1289.
11. Young BA, Taooka Y, Liu S, Askins KJ, Yokosaki Y, Thomas SM, et al. The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner. Mol Biol Cell 2001; 12:3214-25; PMID:11598204.
12. Mambole A, Bigot S, Baruch D, Lesavre P, Halbwachs-Mecarelli L. Human neutrophil integrin {alpha}9{beta}1: up-regulation by cell activation and synergy with {beta}2 integrins during adhesion to endothelium under flow. J Leukoc Biol 2010; 88:321- 7; PMID:20435742; http://dx.doi.org/10.1189/ jlb.1009704.
13. Shang T, Yednock T, Issekutz AC. alpha9beta1 integrin is expressed on human neutrophils and contributes to neutrophil migration through human lung and synovial fibroblast barriers. J Leukoc Biol 1999; 66:809-16; PMID:10577513.
14. Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV Jr., et al. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol 2000; 20:5208-15; PMID:10866676; http://dx.doi. org/10.1128/MCB.20.14.5208-5215. 2000.
15. Staniszewska I, Zaveri S, Del Valle L, Oliva I, Rothman VL, Croul SE, et al. Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res 2007; 100:1308-16; PMID:17413041; http:// dx.doi.org/10.1161/01.RES.0000266662.98355.66.
16. Eto K, Puzon-McLaughlin W, Sheppard D, Sehara- Fujisawa A, Zhang XP, Takada Y. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J Biol Chem 2000; 275:34922-30; PMID:10944520; http://dx.doi.org/10.1074/jbc.M001953200.
17. Staniszewska I, Sariyer IK, Lecht S, Brown MC, Walsh EM, Tuszynski GP, et al. Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins. J Cell Sci 2008; 121:504-13; PMID:18230652; http://dx.doi.org/10. 1242/jcs.000232.
18. Taooka Y, Chen J, Yednock T, Sheppard D. The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 1999; 145:413-20; PMID:10209034; http:// dx.doi.org/10.1083/jcb.145.2.413.
19. Liao YF, Gotwals PJ, Koteliansky VE, Sheppard D, van De Water L. The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem 2002; 277:14467-74; PMID:11839764; http://dx.doi. org/10.1074/jbc.M201100200.
20. Yokosaki Y, Palmer EL, Prieto AL, Crossin KL, Bourdon MA, Pytela R, et al. The integrin alpha 9 beta 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin. J Biol Chem 1994; 269:26691-6; PMID:7523411.
21. Yokosaki Y, Matsuura N, Sasaki T, Murakami I, Schneider H, Higashiyama S, et al. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J Biol Chem 1999; 274:36328-34; PMID:10593924; http://dx.doi. org/10.1074/jbc.274.51. 36328.
22. Vlahakis NE, Young BA, Atakilit A, Sheppard D. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem 2005; 280:4544- 52; PMID:15590642; http://dx.doi.org/ 10.1074/jbc. M412816200.
23. Vlahakis NE, Young BA, Atakilit A, Hawkridge AE, Issaka RB, Boudreau N, et al. Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 2007; 282:15187-96; PMID:17363377; http://dx.doi.org/10.1074/jbc. M609323200.
24. Bazigou E, Xie S, Chen C, Weston A, Miura N, Sorokin L, et al. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 2009; 17:175-86; PMID:19686679; http://dx.doi.org/10.1016/j.devcel.2009.06.017.
25. Schreiber TD, Steinl C, Essl M, Abele H, Geiger K, Müller CA, et al. The integrin alpha9beta1 on hematopoietic stem and progenitor cells: involvement in cell adhesion, proliferation and differentiation. Haematologica 2009; 94:1493-501; PMID:19608669; http://dx.doi.org/10.3324/haematol.2009. 006072.
26. Gupta SK, Vlahakis NE. Integrin a9b1. Unique signaling pathways reveal diverse biological roles. Cell Adhes Migr 2010; 4:194-8; http://dx.doi.org/10. 4161/ cam.4.2.10900.
27. Lydolph MC, Morgan-Fisher M, Høye AM, Couchman JR, Wewer UM, Yoneda A. Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage. Exp Cell Res 2009; 315:3312-24; PMID:19796635; http://dx.doi. org/10.1016/j.yexcr.2009.09.022.
28. Hibi K, Yamakawa K, Ueda R, Horio Y, Murata Y, Tamari M, et al. Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer. Oncogene 1994; 9:611-9; PMID:8290272.
29. Fiorilli P, Partridge D, Staniszewska I, Wang JY, Grabacka M, So K, et al. Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation. Lab Invest 2008; 88:1143-56; PMID:18794852; http:// dx.doi.org/10.1038/labinvest.2008.89.
30. Brown MC, Staniszewska I, Lazarovici P, Tuszynski GP, Del Valle L, Marcinkiewicz C. Regulatory effect of nerve growth factor in alpha9beta1 integrindependent progression of glioblastoma. Neuro-oncol 2008; 10:968-80; PMID:19074980; http://dx.doi. org/10.1215/15228517-2008-0047.
31. Basora N, Desloges N, Chang Q, Bouatrouss Y, Gosselin J, Poisson J, et al. Expression of the alpha9beta1 integrin in human colonic epithelial cells: resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines. Int J Cancer 1998; 75:738- 43; PMID:9495242; http://dx.doi.org/10.1002/ (SICI)1097-0215(19980302)75:5〈738:: AIDIJC12〉3.0.CO;2-2.
32. Ortega P, Moran A, Fernandez-Marcelo T, De Juan C, Frias C, Lopez-Asenjo JA, et al. MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway. Int J Oncol 2010; 36:1209-15; PMID:20372795.
33. Pavlova TV, Kashuba VI, Muravenko OV, Yenamandra SP, Ivanova TA, Zabarovskaia VI, et al. Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome. Mol Biol (Mosk) 2009; 43:313-20; PMID:19425501; http://dx.doi. org/10.1134/S0026893309020137.
34. Gerashchenko GV, Gordiyuk VV, Skrypkina IY, Kvasha SM, Kolesnik OO, Ugryn DD, et al. Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer. Ukr Biokhim Zh 2009; 81:81-7; PMID:20387637.
35. Ghosh A, Ghosh S, Maiti GP, Sabbir MG, Zabarovsky ER, Roy A, et al. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: Clinical and prognostic significance. Cancer Sci 2010; 101:1511-20; PMID:20412120; http://dx.doi.org/10.1111/j.1349- 7006.2010.01551.x.
36. Mitra S, Mazumder Indra D, Bhattacharya N, Singh RK, Basu PS, Mondal RK, et al. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance. Genes Chromosomes Cancer 2010; 49:155-70; PMID:19885927.
37. Arihiro K, Kaneko M, Fujii S, Inai K, Yokosaki Y. Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma. Breast Cancer 2000; 7:19-26; PMID:11029766; http://dx.doi.org/10.1007/ BF02967183.
38. Uhm KO, Lee JO, Lee YM, Lee ES, Kim HS, Park SH. Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma. J Cancer Res Clin Oncol 2010; 136:187-94; PMID:19655168; http://dx.doi.org/10.1007/s00432- 009-0646-9.
39. Park J, Song SH, Kim TY, Choi MC, Jong HS, Kim TY, et al. Aberrant methylation of integrin alpha4 gene in human gastric cancer cells. Oncogene 2004; 23:3474-80; PMID:14990990; http://dx.doi. org/10.1038/sj.onc.1207470.
40. Lin KT, Yeh SH, Chen DS, Chen PJ, Jou YS. Epigenetic activation of alpha4, beta2 and beta6 integrins involved in cell migration in trichostatin A-treated Hep3B cells. J Biomed Sci 2005; 12:803-13; PMID:16132114; http://dx.doi.org/10.1007/s11373-005-9005-2.